EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma
- 21 July 2022
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 41 (35) , 4130-4144
Abstract
Enhancer of zeste homolog 2 (EZH2) and SET domain bifurcated 1 (SETDB1, also known as ESET) are oncogenic methyltransferases implicated in a number of human cancers. These enzymes typically function as epigenetic repressors of target genes by methylating histone H3 K27 and H3-K9 residues, respectively. Here, we show that EZH2 and SETDB1 are essential to proliferation in 3 SCC cell lines, HSC-5, FaDu, and Cal33. Additionally, we find both of these proteins highly expressed in an aggressive stem-like SCC sub-population. Depletion of either EZH2 or SETDB1 disrupts these stem-like cells and their associated phenotypes of spheroid formation, invasion, and tumor growth. We show that SETDB1 regulates this SCC stem cell phenotype through cooperation with ΔNp63α, an oncogenic isoform of the p53-related transcription factor p63. Furthermore, EZH2 is upstream of both SETDB1 and ΔNp63α, activating these targets via repression of the tumor suppressor RUNX3. We show that targeting this pathway with inhibitors of EZH2 results in activation of RUNX3 and repression of both SETDB1 and ΔNp63α, antagonizing the SCC cancer stem cell phenotype. This work highlights a novel pathway that drives an aggressive cancer stem cell phenotype and demonstrates a means of pharmacological intervention.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30CA045508, R01CA190997, R21OD018332, CA247400, CA225134)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- Cold Spring Harbor Laboratory and Northwell Health Affiliation
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 56 references indexed in Scilit:
- Human papillomavirus and cervical cancerThe Lancet, 2013
- Oncogenic role of RUNX3 in head and neck cancerJournal of Cellular Biochemistry, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomasProceedings of the National Academy of Sciences, 2010
- Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomasJournal of Cancer Research and Clinical Oncology, 2008
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 MethylationJournal of Biological Chemistry, 2008
- Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with ΔNp73Carcinogenesis, 2007
- An Autoregulatory Loop Directs the Tissue-Specific Expression of p63 through a Long-Range Evolutionarily Conserved EnhancerMolecular and Cellular Biology, 2006
- Effects of gastroesophageal reflux disease in laryngeal carcinomaClinical Otolaryngology, 2004
- The Human Genome Browser at UCSCGenome Research, 2002